Identifying the genetic association between rheumatoid arthritis and the risk of infectious diseases
- PMID: 40377766
- DOI: 10.1007/s10067-025-07485-x
Identifying the genetic association between rheumatoid arthritis and the risk of infectious diseases
Abstract
Background: Previous evidence suggests an association between rheumatoid arthritis (RA) and infectious diseases, but the causal relationship remains unclear. This study sought to explore causal associations between RA and five common infections: pneumonia, sepsis, urinary tract infections (UTI), skin and subcutaneous tissue infections (SSTI), and bacterial intestinal infections (BII).
Methods: To identify the causal links, we adopted a Mendelian randomization (MR) design utilizing the inverse variance weighted (IVW), weighted median (WM), and MR-Egger approaches. Univariable MR (UVMR) and multivariable MR (MVMR) analyses were performed using pooled genome-wide association studies (GWAS) data. Additionally, various sensitivity analyses were conducted to ensure the reliability of the results.
Results: In the UVMR analysis, RA was potentially associated with elevated risks of pneumonia (OR = 1.034, 95% CI: 1.016-1.052, P < 0.001) and sepsis (OR = 1.079, 95% CI: 1.048-1.110, P = 3.507E-07). This association remained significant after adjusting for smoking, alcohol consumption, or type 2 diabetes mellitus (T2DM) in the MVMR analysis. However, no causal links were found between RA and UTI, SSTI, and BII. Sensitivity analyses showed no detectable heterogeneity or pleiotropy, strengthening the causal inference of results.
Conclusion: Our study provides strong evidence of the association between RA and increased risks of pneumonia and sepsis. Further research is required to validate these findings and elucidate the underlying mechanisms. Key Points • It remains unclear whether the increased susceptibility to infections in RA stems from a genetic predisposition or results from immunosuppressive treatments. • The MR method is employed to assess the relationship between RA and common infectious diseases. • Our MR study supports a potential causal relationship between RA and elevated risks of pneumonia and sepsis.
Keywords: Infections; Mendelian randomization; Pneumonia; Rheumatoid arthritis; Sepsis.
© 2025. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).
Conflict of interest statement
Compliance with ethical standards. Ethics approval and consent to participate: The data were collected from public databases. And there was no ethical approval necessary. Conflict interest: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Unraveling the causal nexus of cathepsins and rheumatoid arthritis: Insights from a two-sample Mendelian randomization framework.Medicine (Baltimore). 2025 Jun 13;104(24):e42805. doi: 10.1097/MD.0000000000042805. Medicine (Baltimore). 2025. PMID: 40527852 Free PMC article.
-
Causal association between rheumatoid arthritis and risk of stroke: A Mendelian randomization study.Clin Neurol Neurosurg. 2024 Sep;244:108465. doi: 10.1016/j.clineuro.2024.108465. Epub 2024 Jul 21. Clin Neurol Neurosurg. 2024. PMID: 39059285
-
Unveiling the genetic association between rheumatoid arthritis and four common hand pathologies.Eur J Med Res. 2025 Jun 19;30(1):492. doi: 10.1186/s40001-025-02695-0. Eur J Med Res. 2025. PMID: 40537869 Free PMC article.
-
Exploring the Links Between Rheumatoid Arthritis and Pulpal-Periapical Diseases: Insights from Meta-Analysis and Two-Sample Mendelian Randomization.J Endod. 2025 Jul;51(7):920-930. doi: 10.1016/j.joen.2025.04.013. Epub 2025 Apr 25. J Endod. 2025. PMID: 40288574
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
References
-
- Kaestner S, Wolff H-J, Braeuer R, Kaestner P (2021) Immunoglobulin deficiencies in treated patients suffering from rheumatoid arthritis. Rheumatol Int 41(7):1273–1280. https://doi.org/10.1007/s00296-021-04871-x - DOI
-
- GBD (2021) Rheumatoid Arthritis Collaborators (2023) Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol 5(10):e594-610. https://doi.org/10.1016/S2665-9913(23)00211-4 - DOI
-
- Hsieh P-H, Wu O, Geue C, McIntosh E, McInnes IB, Siebert S (2020) Economic burden of rheumatoid arthritis: a systematic review of literature in biologic era. Ann Rheum Dis 79(6):771–777. https://doi.org/10.1136/annrheumdis-2019-216243 - DOI
-
- Ozen G, Pedro S, England BR, Mehta B, Wolfe F, Michaud K (2019) Risk of serious infection in patients with rheumatoid arthritis treated with biologic versus nonbiologic disease-modifying antirheumatic drugs. ACR Open Rheumatol 1(7):424–432. https://doi.org/10.1002/acr2.11064 - DOI - PMC
-
- Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR et al (2020) Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet 395(10219):200–211. https://doi.org/10.1016/S0140-6736(19)32989-7 - DOI - PMC
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical